Ownership history in CITIGROUP INC · 26 quarters on record
This page tracks every 13F SEC filing in which CITIGROUP INC reported a position in CUE BIOPHARMA INC (CUE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 132 | +89 | +207.0% | 0.00% | $95 | $0.72 |
| 2024 Q4 | UNCHANGED | 43 | — | 0% | 0.00% | $47 | $1.09 |
| 2024 Q3 | REDUCED | 43 | -5,002 | -99.1% | 0.00% | $33 | $0.76 |
| 2024 Q2 | REDUCED | 5,045 | -1,024 | -16.9% | 0.00% | $6K | $1.24 |
As of 2025 Q4 — sorted by position size